Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03568838
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03568838
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03568838. Randomized; no masking; primary purpose prevention. Start 2018-06-28 (actual); primary completion 2020-05-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
- Acronym
- PENNYWISE
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Enoxaparin
- Lead sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Collaborator
- Medical Research Council
Record details
- Record id
cardio:ct-nct03568838- Content hash
dcb6fbe4a9547b9857764af426d752394091601c56d5132bf23ab8d9b7d9a1de